OPSUMIT

macitentan · Actelion Pharmaceuticals US, Inc.

Drug timelines are a Plus or Pro feature.

43 regulatory and trial events tracked for OPSUMIT, covering 2013-10-18 to 2026-06-05. Get the full timeline:

Most recent: EMA Authorised: Opsumit (macitentan) — Janssen-Cilag International N.V.